Deutsche Bank
DERM icon

Deutsche Bank’s Journey Medical DERM Stock Holding History

Deutsche Bank’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$54.2K Hold
11,560
– – ﹤0.01% 3458
2025
Q4 		$89.1K Buy
+11,560
New +$90.6K ﹤0.01% 3329
2025
Q3 		– Sell
-12,968
Closed -$93.1K – 3628
2025
Q2 		$93.1K Buy
+12,968
New +$89.6K ﹤0.01% 3288

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank's DERM Position: Q1 2026 in Review

Deutsche Bank held its Journey Medical (DERM) position steady in Q1 2026 at 11,560 shares worth $54.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3458.

Deutsche Bank first reported a position in DERM in Q2 2025 and has held it in 3 quarters since. The position peaked at $93.1K in Q2 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Deutsche Bank held 11,560 shares of Journey Medical worth $54.2K as of Q1 2026.
  • Deutsche Bank left its Journey Medical share count unchanged in Q1 2026.
  • Journey Medical made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #3458 holding.
  • Deutsche Bank first reported a position in Journey Medical in Q2 2025 and has held it in 3 quarters since.
  • Deutsche Bank's Journey Medical position peaked at $93.1K in Q2 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.